Patents by Inventor Robert Gellibolian

Robert Gellibolian has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10830677
    Abstract: A filtration device is disclosed for filtering debris from a biofluid sample. In at least one embodiment, the filtration device provides a collection container having a collection chamber defined by a flexible wall, a mouth fluidly communicating with the collection chamber and formed through the collection container at a top end, and a filter device defining a bottom of the collection chamber. A quantitative container has a quantitative chamber in fluid communication with the filter device with the filter device separating the collection chamber from the quantitative chamber. A biofluid sample is introduced into the collection chamber through the mouth, and when the mouth with a collection chamber cap, the flexible wall of the collection container is squeezed to reduce the volume of the collection chamber and force the biofluid sample through the filter device, the filtered biofluid sample thereafter being contained within the quantitative chamber.
    Type: Grant
    Filed: April 12, 2019
    Date of Patent: November 10, 2020
    Assignee: CellectGen, Inc.
    Inventors: Robert Gellibolian, Adam Markaryan
  • Publication number: 20190242798
    Abstract: A filtration device is disclosed for filtering debris from a biofluid sample. In at least one embodiment, the filtration device provides a collection container having a collection chamber defined by a flexible wall, a mouth fluidly communicating with the collection chamber and formed through the collection container at a top end, and a filter device defining a bottom of the collection chamber. A quantitative container has a quantitative chamber in fluid communication with the filter device with the filter device separating the collection chamber from the quantitative chamber. A biofluid sample is introduced into the collection chamber through the mouth, and when the mouth with a collection chamber cap, the flexible wall of the collection container is squeezed to reduce the volume of the collection chamber and force the biofluid sample through the filter device, the filtered biofluid sample thereafter being contained within the quantitative chamber.
    Type: Application
    Filed: April 12, 2019
    Publication date: August 8, 2019
    Applicant: CellectGen, Inc.
    Inventors: Robert Gellibolian, Adam Markaryan
  • Patent number: 10302535
    Abstract: A filtration device is disclosed for filtering debris from a biofluid sample. In at least one embodiment, the filtration device provides a collection container having a collection chamber defined by a flexible wall, a mouth fluidly communicating with the collection chamber and formed through the collection container at a top end, and a filter device defining a bottom to the collection chamber. A quantitative container has a quantitative chamber in fluid communication with the filter device with the filter device separating the collection chamber from the quantitative chamber. A biofluid sample is introduced into the collection chamber through the mouth, and when the mouth with a collection chamber cap, the flexible wall of the collection container is squeezed to reduce the volume of the collection chamber and force the biofluid sample through the filter device, the filtered biofluid sample thereafter being contained within the quantitative chamber.
    Type: Grant
    Filed: August 7, 2016
    Date of Patent: May 28, 2019
    Assignee: CellectGen, Inc.
    Inventors: Robert Gellibolian, Adam Markaryan
  • Patent number: 9816087
    Abstract: The present specification discloses filtration devices for processing a biofluid sample, methods of purifying a biofluid sample using the disclosed filtration devices, and systems comprising components of the filtration devices. The filtration device generally includes a collection container, a quantitative container, a filter, and a plunger slidably inserted through a plunger attachment. In a first configuration, the quantitative container is axially slidably inserted within the collection chamber, with fluid communication between the quantitative chamber and the collection chamber provided through the filter. In a second configuration, the filter and the collection container are separated from the quantitative container, the plunger attachment is fitted to the quantitative chamber open end with at least a portion of the plunger positioned within the quantitative chamber.
    Type: Grant
    Filed: September 11, 2014
    Date of Patent: November 14, 2017
    Assignee: CellectGen, Inc.
    Inventors: Robert Gellibolian, John Stump, Adam Markaryan
  • Publication number: 20170030811
    Abstract: The present specification discloses filtration devices for processing a biofluid sample, methods of purifying a biofluid sample using the disclosed filtration devices, and systems comprising components of the filtration devices.
    Type: Application
    Filed: August 7, 2016
    Publication date: February 2, 2017
    Applicant: CellectGen, LLC
    Inventors: Robert Gellibolian, Adam Markaryan
  • Patent number: 9212067
    Abstract: According to the present invention, a fluid and/or aqueous additive delivery system is provided. According to the present invention, a modular fluid container is described for consumption of liquids. Fluid containers according to the present invention include any combination of four distinct modular components; (1) an end-point filter purification module for removal of impurities from water, (2) a UV purification module for emitting ultraviolet (UV) light in a germicidal spectrum for disinfection, (3) a tablet storage and dispensing module to emit ultraviolet (UV) light in a germicidal spectrum for disinfection of a volume of drink liquid held in the container, (4) a flow meter module for quantitatively monitoring hydration in real time. The user can personalize the bottle with any or all modules that are required.
    Type: Grant
    Filed: May 30, 2013
    Date of Patent: December 15, 2015
    Assignee: FLOZINC, LLC
    Inventors: Robert Gellibolian, John Stump
  • Publication number: 20150072346
    Abstract: The present specification discloses filtration devices for processing a biofluid sample, methods of purifying a biofluid sample using the disclosed filtration devices, and systems comprising components of the filtration devices.
    Type: Application
    Filed: September 11, 2014
    Publication date: March 12, 2015
    Applicant: CellectGen, Inc.
    Inventors: Robert Gellibolian, John Stump
  • Publication number: 20130319915
    Abstract: According to the present invention, a fluid and/or aqueous additive delivery system is provided. According to the present invention, a modular fluid container is described for consumption of liquids. Fluid containers according to the present invention include any combination of four distinct modular components; (1) an end-point filter purification module for removal of impurities from water, (2) a UV purification module for emitting ultraviolet (UV) light in a germicidal spectrum for disinfection, (3) a tablet storage and dispensing module to emit ultraviolet (UV) light in a germicidal spectrum for disinfection of a volume of drink liquid held in the container, (4) a flow meter module for quantitatively monitoring hydration in real time. The user can personalize the bottle with any or all modules that are required.
    Type: Application
    Filed: May 30, 2013
    Publication date: December 5, 2013
    Applicant: Floz, Inc.
    Inventors: Robert Gellibolian, John Stump
  • Publication number: 20070264667
    Abstract: Embodiments of the present invention are directed to sensitive, specific, and commercially feasible assays for transferase activity. Various embodiments of the present invention include artificial, multifunctional substrates specific for particular transferases that are chemically altered by the transferases to produce easily detectable, modified, multifunctional substrates. In one class of embodiments, the artificial, multifunctional substrate comprises a small-molecule-substrate component, or small-molecule-substrate-analog component, linked by a linking component to a biopolymer-substrate-mimetic or biopolymer-substrate-analog component. At least two, generally well-separated reporter moieties are included in the artificial, multifunctional substrate.
    Type: Application
    Filed: September 3, 2004
    Publication date: November 15, 2007
    Inventors: Robert Gellibolian, Riaz Rouhani
  • Patent number: 7192710
    Abstract: Methods and compositions for high-throughput identification of protein/nucleic acid binding pairs are provided. In the subject methods, a nucleic acid probe array, e.g., a molecular beacon probe array, is contacted with a target nucleic acid population to produce a hybridized array. The resultant hybridized array is then contacted with a population of proteins to produce a protein bound array. Any resultant array surface bound target nucleic acid/protein complexes are then detected to identify protein/nucleic acid binding pairs. In certain embodiments, the protein and/or nucleic acid members of the identified protein/nucleic acid binding pairs are further characterized. Also provided are systems and kits for use in practicing the subject methods. The subject invention finds use in a variety of different applications.
    Type: Grant
    Filed: March 29, 2004
    Date of Patent: March 20, 2007
    Assignee: Agilent Technologies, Inc.
    Inventors: Robert Gellibolian, Eric M. Leproust
  • Publication number: 20050003395
    Abstract: Methods and compositions for high-throughput identification of protein/nucleic acid binding pairs are provided. In the subject methods, a nucleic acid probe array, e.g., a molecular beacon probe array, is contacted with a target nucleic acid population to produce a hybridized array. The resultant hybridized array is then contacted with a population of proteins to produce a protein bound array. Any resultant array surface bound target nucleic acid/protein complexes are then detected to identify protein/nucleic acid binding pairs. In certain embodiments, the protein and/or nucleic acid members of the identified protein/nucleic acid binding pairs are further characterized. Also provided are systems and kits for use in practicing the subject methods. The subject invention finds use in a variety of different applications.
    Type: Application
    Filed: March 29, 2004
    Publication date: January 6, 2005
    Inventors: Robert Gellibolian, Eric Leproust
  • Patent number: 6713262
    Abstract: Methods and compositions for high-throughput identification of protein/nucleic acid binding pairs are provided. In the subject methods, a nucleic acid probe array, e.g., a molecular beacon probe array, is contacted with a target nucleic acid population to produce a hybridized array. The resultant hybridized array is then contacted with a population of proteins to produce a protein bound array. Any resultant array surface bound target nucleic acid/protein complexes are then detected to identify protein/nucleic acid binding pairs. In certain embodiments, the protein and/or nucleic acid members of the identified protein/nucleic acid binding pairs are further characterized. Also provided are systems and kits for use in practicing the subject methods. The subject invention finds use in a variety of different applications.
    Type: Grant
    Filed: June 25, 2002
    Date of Patent: March 30, 2004
    Assignee: Agilent Technologies, Inc.
    Inventors: Robert Gellibolian, Eric M. Leproust
  • Publication number: 20030036065
    Abstract: A method and system for signal generation and signal amplification from an array containing bound, unlabeled target molecules. Following exposure of the array to a sample solution containing unlabaled target RNA molecules, blunt ends are generated on each probe/target double-stranded hybrid labeled primer oligonucleotide linker is then bound to the blunt ends. Next, in an iterative, inner process, additional layers of labeled oligonucleotide, linkers are added, shell-by-shell, to form a dendrimer-like molecular complex bound through the oligonucleotide linker to the probe/target hybrid.
    Type: Application
    Filed: August 17, 2001
    Publication date: February 20, 2003
    Inventor: Robert Gellibolian